相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Resolution of Allergic Inflammation and Airway Hyperreactivity Is Dependent upon Disruption of the T1/ST2-IL-33 Pathway
Jennifer Kearley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Inhibition of Interleukin-33 Signaling Attenuates the Severity of Experimental Arthritis
Gaby Palmer et al.
ARTHRITIS AND RHEUMATISM (2009)
Mature interleukin-33 is produced by calpain-mediated cleavage in vivo
Morisada Hayakawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Alexander U. Luethi et al.
IMMUNITY (2009)
Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage
Dominique Talabot-Ayer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
J. Chapuis et al.
MOLECULAR PSYCHIATRY (2009)
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Corinne Cayrol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Secretion of Soluble ST2-Possible Explanation for Systemic Immunosuppression after Heart Surgery
T. Szerafin et al.
THORACIC AND CARDIOVASCULAR SURGEON (2009)
Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation
Axel M. Kuchler et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Elevated levels of soluble ST2 protein in dengue virus infected patients
Aniuska Becerra et al.
CYTOKINE (2008)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure
Shafiq U. Rehman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells
David Moulin et al.
CYTOKINE (2007)
IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells
Shafaqat Ali et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
IL-33 can promote survival, adhesion and cytokine production in human mast cells
Motoyasu Iikura et al.
LABORATORY INVESTIGATION (2007)
Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation
Hiroko Hayakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation
Niarnh E. Mangan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Virginie Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury
Hui Yin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma
M Brunner et al.
INTENSIVE CARE MEDICINE (2004)
The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis
S Tajima et al.
CHEST (2003)
Identification of human ST2 protein in the sera of patients with autoimmune diseases
K Kuroiwa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)